CapsoVision (CV) Price to Sales (2025 - 2026)

CapsoVision's (CV) quarterly Price to Sales came in at 104.1 in Q2 2026, up 55.38% quarter-over-quarter from 67.0 in Q4 2025.

Analysis

CapsoVision (CV) Price to Sales (2025 - 2026) Analysis & Trends

CapsoVision has disclosed Price to Sales across 2 years of filings, most recently posting 104.1 for Q2 2026.

In Q2 2026, Price to Sales changed N/A year-over-year to 104.1; the TTM figure through Jun 2026 stood at 26.31 (changed N/A YoY), while the FY2025 annual figure was 19.37, changed N/A from the prior year.
Price to Sales came in at 104.1 for Q2 2026 at CapsoVision, up from 67.0 in the prior quarter.
In the past five years, Price to Sales ranged from a high of 104.1 in Q2 2026 to a low of 23.32 in Q3 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	GE HealthCare Technologies	29.54 Bn	27.44 Bn	2.18 Bn
2	Lantheus Holdings	6.56 Bn	5.97 Bn	241.86 Mn
3	Heartflow	4.04 Bn	3.66 Bn	53.19 Mn
4	Neogen	2.59 Bn	2.41 Bn	107.80 Mn
5	Butterfly Network	1.96 Bn	1.84 Bn	23.29 Mn
6	Ceribell	928.74 Mn	799.48 Mn	25.94 Mn
7	QuidelOrtho	866.04 Mn	742.64 Mn	-
8	Varex Imaging	779.06 Mn	679.86 Mn	76.70 Mn
9	Prenetics Global	339.99 Mn	280.94 Mn	30.20 Mn
10	CapsoVision	318.60 Mn	309.52 Mn	1.87 Mn

Historic Data

Download Data